AKBM.OL OSL
Aker BioMarine AS
1W: -6.2%
1M: -23.5%
3M: +2.0%
YTD: +5.8%
1Y: +22.1%
3Y: +274.8%
5Y: +244.6%
kr 122.00 ($12.69)
+0.00 (+0.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$385M
-0.7% ▼
5Y CAGR: -11.3%
Total Liabilities
$241M
+12.8% ▲
5Y CAGR: -6.0%
Shareholders Equity
$144M
-17.1% ▼
5Y CAGR: -17.4%
Cash & Investments
$17M
+12.7% ▲
5Y CAGR: +13.2%
Total Debt
$182M
+23.5% ▲
5Y CAGR: -5.6%
Net Debt
$165M
+24.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $9M | $21M | $25M | $15M | $17M |
| Short-Term Investments | $0 | $0 | $2M | $0 | $0 |
| Cash & ST Investments | $9M | $21M | $28M | $15M | $17M |
| Net Receivables | $50M | $60M | $58M | $47M | $49M |
| Inventory | $138M | $183M | $184M | $96M | $107M |
| Other Current Assets | $23M | $16M | $16M | $38M | $17M |
| Total Current Assets | $240M | $299M | $290M | $202M | $190M |
| Property, Plant & Equip. | $339M | $343M | $351M | $52M | $56M |
| Goodwill & Intangibles | $172M | $163M | $151M | $99M | $117M |
| Long-Term Investments | $100K | $10M | $100K | $400K | $18M |
| Other Non-Current Assets | $7M | $18M | $35M | $35M | $1M |
| Total Non-Current Assets | $518M | $524M | $537M | $186M | $195M |
| Total Assets | $757M | $822M | $827M | $387M | $385M |
| — Liabilities — | |||||
| Accounts Payable | $25M | $39M | $30M | $16M | $51M |
| Short-Term Debt | $26M | $43M | $44M | $6M | $23M |
| Deferred Revenue | $18M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$14M | $3M | $34M | $7M | $3M |
| Total Current Liabilities | $77M | $105M | $113M | $53M | $77M |
| Long-Term Debt | $287M | $328M | $339M | $139M | $159M |
| Other Non-Current Liab. | $16M | $0 | $4M | $20M | $0 |
| Total Non-Current Liabilities | $310M | $339M | $348M | $160M | $164M |
| Total Liabilities | $387M | $444M | $461M | $214M | $241M |
| — Equity — | |||||
| Common Stock | $76M | $76M | $76M | $76M | $0 |
| Retained Earnings | -$204M | -$194M | -$203M | -$396M | $0 |
| Accumulated OCI | -$31M | -$33M | -$36M | -$36M | $0 |
| Total Stockholders Equity | $370M | $379M | $367M | $174M | $144M |
| Total Liabilities & Equity | $757M | $822M | $827M | $387M | $385M |
| — Key Metrics — | |||||
| Total Debt | $325M | $381M | $393M | $148M | $182M |
| Net Debt | $316M | $360M | $368M | $132M | $165M |
| Total Investments | $100K | $10M | $2M | $400K | $18M |